Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Staszewski, Schlomo; O Morales-Ramirez, Javier; T. Tashima, Karen; Rachlis, Anita; J. Skiest, Daniel; Stanford, James; Stryker, Richard; C. Johnson, Philip; Labriola, Dominic; Farina, Dianne; J. Manion, Douglas; Ruíz, Nancy

doi:10.1056/nejm199912163412501

Public

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Published in New England Journal of Medicine • Dec 16, 1999

Authors:

Schlomo Staszewski

Javier O Morales-Ramirez

Karen T. Tashima

Abstract

BACKGROUND: Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). We compared two regimens containing efavirenz, one with a protease inhibitor and the other with two nucleoside reverse-transcriptase inhibitors, with a standard three-drug regimen...

Subject

Efavirenz

Indinavir

Lamivudine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!